156 related articles for article (PubMed ID: 9296893)
1. [Plasminogen tissue activator and plasminogen tissue inhibitor in type II diabetes].
Rość D; Drewniak W; Kotschy M; Graczykowska-Koczorowska A; Raukuć D
Pol Merkur Lekarski; 1997 Jan; 2(7):24-5. PubMed ID: 9296893
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
4. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
[TBL] [Abstract][Full Text] [Related]
5. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
6. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
[TBL] [Abstract][Full Text] [Related]
7. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
[TBL] [Abstract][Full Text] [Related]
8. [Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)].
Hayashi T
Rinsho Byori; 1994 Apr; 42(4):346-51. PubMed ID: 8176842
[TBL] [Abstract][Full Text] [Related]
9. [Tissue plasminogen activator, its inhibitor and other parameters of fibrinolysis in blood of patients operated for mild hypertrophy of the prostate].
Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F; Cwiklińska-Jurkowska M
Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1096-7. PubMed ID: 1284828
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic activity in Chinese patients with diabetes or hyperlipidemia in comparison with healthy controls.
Ho CH; Jap TS
Thromb Haemost; 1991 Jan; 65(1):3-6. PubMed ID: 1902595
[TBL] [Abstract][Full Text] [Related]
11. [Tissue plasminogen activator antigen (t-PA Ag) and tissue plasminogen activator inhibitor (PAI-1) in the course of hemodialysis in patients with chronic renal failure].
Piatkowska M; Kotschy M; Nartowicz E; Rajewski W
Pol Merkur Lekarski; 1997 Jan; 2(9):205-7. PubMed ID: 10907030
[TBL] [Abstract][Full Text] [Related]
12. A kinetic model of the circulatory regulation of tissue plasminogen activator.
Chandler WL
Thromb Haemost; 1991 Sep; 66(3):321-8. PubMed ID: 1746003
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
14. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor].
Giedrojć J; Stankiewicz A; Walkowiak M; Galar M; Bielawiec M
Klin Oczna; 1996; 98(4):283-5. PubMed ID: 9463119
[TBL] [Abstract][Full Text] [Related]
15. [Tissue plasminogen activator (t-PA) in aqueous humor of patients with cataract].
Kotschy M; Kałuzny J; Kaniasty M; Zekanowska E; Kropińska E
Klin Oczna; 1996 Mar; 98(3):201-3. PubMed ID: 9019589
[TBL] [Abstract][Full Text] [Related]
16. [Hemostatic disturbances in chronic myeloid leukemia].
Rość D; Kremplewska-Nalezyta E; Gadomska G; Bielis L
Wiad Lek; 2007; 60(3-4):138-42. PubMed ID: 17726865
[TBL] [Abstract][Full Text] [Related]
17. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
[TBL] [Abstract][Full Text] [Related]
18. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
20. [Plasminogen activator and PAI. Detection in aqueous humor of the human eye].
Steinkamp GW; Hattenbach LO; Heider HW; Scharrer I
Ophthalmologe; 1993 Feb; 90(1):73-5. PubMed ID: 8443455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]